Development and validation of UV-visible spectrophotometric method for determination of Bicalutamide in bulk and in pharmaceutical dosage form

  • V. Hariharasudhan Department of Pharmaceutical Analysis, Jaya College of Paramedical Sciences, College of Pharmacy, Chennai, Tamil Nadu, India-602024.
  • P. Divakar Department of Pharmaceutical Analysis, Jaya College of Paramedical Sciences, College of Pharmacy, Chennai, Tamil Nadu, India-602024.
  • A. Maheswaran Department of Pharmaceutical Analysis, Jaya College of Paramedical Sciences, College of Pharmacy, Chennai, Tamil Nadu, India-602024.
  • D. Saravanan Department of Pharmaceutical Analysis, Jaya College of Paramedical Sciences, College of Pharmacy, Chennai, Tamil Nadu, India-602024.
Keywords: Bicalutamide, Validation, UV-Visible Spectrophotometer, Estimation

Abstract

The aim of the present study, simple and sensitive spectrophotometric method was developed for the estimation and validation of Bicalutamide in bulk and Pharmaceutical dosage form by UV spectroscopy as per ICH guidlines. The maximum absorbance (λmax) of Bicalutamide in methanol was found to be 272 nm against methanol as a blank. The Bicalutamide obeys the Beers law in the concentration range 2.5 to 15 μg/ml with a correlation coefficient of 0.999. The proposed method was applied for the estimation of Bicalutamide in pharmaceutical dosage form and % purity was found to be 99.96 to 100.06 that indicate the good agreement with the label claim. The accuracy of the proposed method was determined by recovery study at three different levels (50%, 100%, and 150%). The % recovery was found to be 99.6 to 100.2%. The precision study was carried out by intraday and interday. The % RSD was found to be < 2 which indicates that the method is precise. The proposed method was a fast technique for the routine analysis of Bicalutamide in bulk and pharmaceutical dosage form.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Fradet, Y. (2004). Bicalutamide (Casodex) in the treatment of prostate cancer. Expert review of anticancer therapy, 4(1), 37–48. https://doi.org/10.1586/14737140.4.1.37

Cockshott, I. D., Oliver, S. D., Young, J. J., Cooper, K. J., & DC Jones (1997). The effect of food on the pharmacokinetics of the bicalutamide ('Casodex') enantiomers. Biopharmaceutics & drug disposition, 18(6), 499–507. https://doi.org/10.1002/(sici)1099-081x(199708)18:6<499::aid-bdd37>3.0.co;2-j

Cockshott I. D. (2004). Bicalutamide: clinical pharmacokinetics and metabolism. Clinical pharmacokinetics, 43(13), 855–878. https://doi.org/10.2165/00003088-200443130-00003

Sancheti, P. P., Vyas, V. M., Shah, M., Karekar, P., & Pore, Y. V. (2008). Spectrophotometric estimation of bicalutamide in tablets. Indian journal of pharmaceutical sciences, 70(6), 810–812. https://doi.org/10.4103/0250-474X.49131

Saravanan, G., Rao, B. M., Ravikumar, M., Suryanarayana, M. V., Someswararao, N., Acharyulu, P. V. R. (2007). A Stability-Indicating LC Assay Method for Bicalutamide. Chromatographia. 66, 219–222.

Smith, A. A., Kannan, K., Manavalan, R., Rajendiran, N. (2007). Spectral Characteristics of Bicalutamide Drug in Different Solvents and β-Cyclodextrin. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 58, 161–167.

Török, R., Bor, A., Orosz, G., Lukács, F., Armstrong, D. W., & Péter, A. (2005). High-performance liquid chromatographic enantioseparation of bicalutamide and its related compounds. Journal of chromatography. A, 1098(1-2), 75–81. https://doi.org/10.1016/j.chroma.2005.08.056

Published
30-09-2020
How to Cite
V. Hariharasudhan, P. Divakar, A. Maheswaran, & D. Saravanan. (2020). Development and validation of UV-visible spectrophotometric method for determination of Bicalutamide in bulk and in pharmaceutical dosage form. International Journal of Research In Pharmaceutical Chemistry and Analysis, 1(4), 107-111. https://doi.org/10.33974/ijrpca.v2i1.235
Section
Research Article